France analyst views: UBS turns positive again on Sartorius Stedim Biotech
UBS upgraded Sartorius Stedim Biotech to buy, raising its price target to €260 from €220. JP Morgan upgraded Michelin to overweight, increasing its target to €42 from €35. JP Morgan also trimmed Elis's target to €28.20, while UBS raised Getlink's to €19.80.

